| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |